1.05Open1.05Pre Close0 Volume91 Open Interest10.00Strike Price0.00Turnover41.58%IV0.56%PremiumJan 17, 2025Expiry Date1.00Intrinsic Value100Multiplier20DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.8494Delta0.2857Gamma8.57Leverage Ratio-0.0043Theta-0.0033Rho-7.28Eff Leverage0.0049Vega
Immersion Stock Discussion
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Monday, 16th December at 8:50 am
Successful Completion of All Planned Implants in GLP Study
enVVe Delivery System Demonstrates Consistent Performance
Company Maintains Timeline for IDE Application Submission by Mid-2025, Pending GLP Study Results
IRVINE, CA / ACCESSWIRE / December 16, 2024 / enVVeno Medical Corporation (NASDAQ: NVNO) ("enVVeno" or the "Company"), a compan...
Risk Level: 6 (Moderate Risk)
The risk assessment for Immersion Corporation at a score of 6 signifies moderate risk for potential investors. The company's fundamentals, such as solid profitability and reasonable P/E ratio, provide a cushion to investors; however, the absence of bullish news and lackluster sector interest increase the volatility risk. The stock's strong foundation with clear support levels counters some of the risk, but the limi...
oversold undervalued
P/L= +1.71%
loading...
loading...
No comment yet